CD84 and breast carcinoma: SLAMF5/CD84 was detected as an identifying marker for myeloid-derived suppressor cells (MDSCs) in breast cancer in a mouse model, and in vitro experiments showed that PBMC-derived human MDSCs upregulate SLAMF5.